ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $490,000 | -89.2% | 39,415 | -88.1% | 0.02% | -87.9% |
| Q3 2016 | $4,550,000 | -18.8% | 332,388 | -56.2% | 0.14% | -23.8% |
| Q2 2016 | $5,605,000 | -10.9% | 758,519 | -22.9% | 0.18% | +2.8% |
| Q1 2016 | $6,291,000 | +108.9% | 984,441 | +106.7% | 0.18% | +153.5% |
| Q4 2015 | $3,012,000 | +74.2% | 476,178 | +60.9% | 0.07% | +31.5% |
| Q3 2015 | $1,729,000 | -72.8% | 295,992 | -61.5% | 0.05% | -68.6% |
| Q2 2015 | $6,356,000 | -35.6% | 768,562 | +43.3% | 0.17% | -21.8% |
| Q3 2013 | $9,866,000 | +171.0% | 536,211 | +157.6% | 0.22% | +122.2% |
| Q2 2013 | $3,640,000 | – | 208,120 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
| DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
| Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
| BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
| SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
| OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
| Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
| Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |